Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, shared a post on X:
“Nice interview with Diogo Silva re N-of-1 biomarker matched therapy and exceptional GBM responses.”
Title: Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies
Authors: Umut Dişel, Shumei Kato, Aditya Shreenivas, Ayca Ersen Danyeli, Manmeet Ahluwalia, Razelle Kurzrock․
Other articles featuring Razelle Kurzrock on OncoDaily.